Inventor · disambiguated record
Kohei Inamura
Also filed as: INAMURA KOHEI
4 granted patents·5 pending applications·0 citations·filing 2001–2025
53Inventor score
Files withASTELLAS PHARMA INC8
Top patents by PatentIndex Score
9 records- 0167US2025340561A1Quinazoline compound for inducing degradation of g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2025·Application pending·0 cites
- 0264US12384794B2Quinazoline compound for inducing degradation of G12D mutant KRAS proteinASTELLAS PHARMA INC·Filed 2022·Granted Aug 12, 2025·0 cites·37 claims
- 0363US2025145631A1Heterocyclic compound acting on g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0462US2025388569A1Heterocyclic compound for inhibiting and/or inducing degradation of kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0560US2025206751A1Heterocyclic compound for inducing degradation of g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0644US7097990B2Method of screening cell death inhibitorASTELLAS PHARMA INC·Filed 2002·Granted Aug 29, 2006·0 cites·17 claims
- 0743US7211406B2Potassium channelASTELLAS PHARMA INC·Filed 2001·Granted May 1, 2007·0 cites·7 claims
- 0842US2003176342A1Novel potassium channelFiled 2001·Application pending·0 cites
- 0941US7476508B2Method of screening agent for improving memory and learning abilityASTELLAS PHARMA INC·Filed 2004·Granted Jan 13, 2009·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Kohei Inamura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →